“Bedaquiline-a Potential Inhibitor of COVID-19 Main Protease Based on Molecular Docking”. 2021. International Journal of Research in Pharmacology & Pharmacotherapeutics 9 (2): 136-44. https://doi.org/10.61096/ijrpp.v9.iss2.2020.136-144.